<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Sch of Molecular. Genetics &amp; Pop Health</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/71BBD3D8-65FD-4B29-BF3D-CA86446E12C7"><gtr:id>71BBD3D8-65FD-4B29-BF3D-CA86446E12C7</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:otherNames>James</gtr:otherNames><gtr:surname>Brophy</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0301172"><gtr:id>A29C706F-B927-404C-86FD-887E97CCE89B</gtr:id><gtr:title>The role of neurofascin in myelinated nerves</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0301172</gtr:grantReference><gtr:abstractText>Contributing to the public understanding of neuroscience is an explicit goal of The Centre for Neuroscience Research at Edinburgh University (see http://www.cnr.ed.ac.uk). Each year and between March 15th and 21st in 2004 we host Brain Awareness Week, as part of the Dana Alliance for Brain Initiatives. 
 We also believe it to be very important that MS patients, through their local groups, are kept fully apprised of the research that is conducted in their name. Hence, I regularly address local MS groups in order to inform them of progress, not only in our own work, but in MS-related research in general. My participation in the Scottish MS Network ensures that dialogue with other MS professionals is maintained. We also present our work at the annual research meeting of the UK MS Society.</gtr:abstractText><gtr:technicalSummary>Myelinating glia are crucial for rapid nerve impulse transmission; they are also believed to have a vital role in promoting axon survival. Thus, in the demyelinating disease multiple sclerosis, the early stages of axon injury are probably related to the presence of inflammatory mediators in active lesions. However, at later stages, axon loss proceeds in the absence of obvious inflammatory activity, indicating that neurodegeneration in chronically demyelinated plaques may be due to the loss of contact with myelin-forming glia. In order to determine how myelin-forming glia promote neuron survival, the cell-surface molecules that mediate axon-glia interaction must be identified. The major site of physical contact between axons and glia is the paranodal junction, and much has been learned in recent years about the molecular composition of this specialized adhesion zone. The interacting proteins Caspr (also known as Paranodin) and Contactin were identified first in the paranodal axolemma. We recently characterized an isoform of Neurofascin, NF155, as the likely glial receptor for the axonal Caspr/Contactin complex. We have now shown that mice lacking a functional Neurofascin gene do not form septate-like axoglial junctions indicating that NF155 is indeed the glial component of the junctional complex. These mutants also lack other Neurofascin isoforms which probably accounts for the early lethality of the mutation. In this small programme we plan to use a conditional targeting strategy to distinguish the role of NF155 at the paranodal junction from the function of other Neurofascin isoforms, particularly NF186 at the node. We will focus primarily on the structure and function of the axoglial junction since it is of particular relevance to demyelinating disease. We will also determine Neurofascin?s function at the node of Ranvier since NF186 may have an important role in clustering sodium channels. Understanding the role of myelin-forming glia in preventing neuron death is of fundamental importance in MS. We believe that the insights gained from this work may have wider significance, since cell death is a general feature of neurodegenerative disease.</gtr:technicalSummary><gtr:fund><gtr:end>2009-04-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>682211</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>MS Groups</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>643BE3F4-B386-489C-8F83-4BB82138BD7E</gtr:id><gtr:impact>About 40 patients and carers attended talks

Many questions.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007,2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1600000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>MRC Research Grant</gtr:department><gtr:description>MRC Project Grant</gtr:description><gtr:end>2017-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/L011379/1</gtr:fundingRef><gtr:id>27C25F8B-DE7E-4C1B-9237-68927FBC40E5</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2014-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Floxed neurofascin mice and transgenic neurofascin mice</gtr:description><gtr:id>ED1433A9-166B-4E5F-8739-57623AD43DB3</gtr:id><gtr:impact>Papers</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Transgenic and floxed mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D854DA36-D456-4CFB-9094-A957B1E2F485"><gtr:id>D854DA36-D456-4CFB-9094-A957B1E2F485</gtr:id><gtr:title>A critical role for Neurofascin in regulating action potential initiation through maintenance of the axon initial segment.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4679552877dd045f21166b78e846db58"><gtr:id>4679552877dd045f21166b78e846db58</gtr:id><gtr:otherNames>Zonta B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A9E31C28-2765-48E6-BED4-ABCF59AD607E"><gtr:id>A9E31C28-2765-48E6-BED4-ABCF59AD607E</gtr:id><gtr:title>Neurofascins are required to establish axonal domains for saltatory conduction.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/05c2278fefa57da5cc7af6a34321b5d1"><gtr:id>05c2278fefa57da5cc7af6a34321b5d1</gtr:id><gtr:otherNames>Sherman DL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/59102E90-1D3D-483B-B16E-792E7D973CA0"><gtr:id>59102E90-1D3D-483B-B16E-792E7D973CA0</gtr:id><gtr:title>Glial and neuronal isoforms of Neurofascin have distinct roles in the assembly of nodes of Ranvier in the central nervous system.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4679552877dd045f21166b78e846db58"><gtr:id>4679552877dd045f21166b78e846db58</gtr:id><gtr:otherNames>Zonta B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C4848C74-3434-4F80-8F1B-60AC2A20E82D"><gtr:id>C4848C74-3434-4F80-8F1B-60AC2A20E82D</gtr:id><gtr:title>Novel forms of neurofascin 155 in the central nervous system: alterations in paranodal disruption models and multiple sclerosis.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/63b0066d6bb6019123bb12469491c6c0"><gtr:id>63b0066d6bb6019123bb12469491c6c0</gtr:id><gtr:otherNames>Pomicter AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E5A4E9C5-33C3-45D0-98DA-C1CB5F7EF4F8"><gtr:id>E5A4E9C5-33C3-45D0-98DA-C1CB5F7EF4F8</gtr:id><gtr:title>A glial signal consisting of gliomedin and NrCAM clusters axonal Na+ channels during the formation of nodes of Ranvier.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0cb96ee3f67b6e61e52b43f55ec22c11"><gtr:id>0cb96ee3f67b6e61e52b43f55ec22c11</gtr:id><gtr:otherNames>Feinberg K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7C9C40E5-583E-4C3B-8541-3447ED28FE23"><gtr:id>7C9C40E5-583E-4C3B-8541-3447ED28FE23</gtr:id><gtr:title>Disruption of neurofascin localization reveals early changes preceding demyelination and remyelination in multiple sclerosis.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2de6f3ef5361e4a27c73aab4aad7e4eb"><gtr:id>2de6f3ef5361e4a27c73aab4aad7e4eb</gtr:id><gtr:otherNames>Howell OW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A75ADB31-6B70-4C60-9332-A92172DB17F5"><gtr:id>A75ADB31-6B70-4C60-9332-A92172DB17F5</gtr:id><gtr:title>A functional FERM domain binding motif in neurofascin.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular neurosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9aeae27b6f75d4cc5a995c435d3009b9"><gtr:id>9aeae27b6f75d4cc5a995c435d3009b9</gtr:id><gtr:otherNames>Gunn-Moore FJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1044-7431</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0301172</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>